These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19768421)

  • 1. Prioritization of pandemic influenza vaccine: rationale and strategy for decision making.
    Schwartz B; Orenstein WA
    Curr Top Microbiol Immunol; 2009; 333():495-507. PubMed ID: 19768421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines for seasonal and pandemic influenza.
    Nichol KL; Treanor JJ
    J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for broad global access to pandemic influenza vaccines.
    Edwards KM; Sabow A; Pasternak A; Boslego JW
    Curr Top Microbiol Immunol; 2009; 333():471-93. PubMed ID: 19768420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prioritization strategies for pandemic influenza vaccine in 27 countries of the European Union and the Global Health Security Action Group: a review.
    Straetemans M; Buchholz U; Reiter S; Haas W; Krause G
    BMC Public Health; 2007 Sep; 7():236. PubMed ID: 17825095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges.
    Hessel L;
    Influenza Other Respir Viruses; 2009 Jul; 3(4):165-70. PubMed ID: 19627373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.
    Khazeni N; Hutton DW; Garber AM; Owens DK
    Ann Intern Med; 2009 Dec; 151(12):840-53. PubMed ID: 20008760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine supply: building long-term sustainability.
    Hehme N; Colegate T; Palache B; Hessel L
    Vaccine; 2008 Sep; 26 Suppl 4():D23-6. PubMed ID: 19230154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hospital-based strategy for setting priorities for antiviral prophylaxis during an influenza pandemic.
    Hsu EB; Millin MG
    Biosecur Bioterror; 2008 Jun; 6(2):171-8. PubMed ID: 18563994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccines: a main problem in control of pandemics.
    Ghendon Y
    Eur J Epidemiol; 1994 Aug; 10(4):485-6. PubMed ID: 7843363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus.
    Carter NJ; Plosker GL
    BioDrugs; 2008; 22(5):279-92. PubMed ID: 18778110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing the dose of pre-pandemic influenza vaccines to reduce the infection attack rate.
    Riley S; Wu JT; Leung GM
    PLoS Med; 2007 Jun; 4(6):e218. PubMed ID: 17579511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Principles and methods for vaccine epidemiology: evaluation of immunogenicity and effectiveness of pandemic H1N1 influenza vaccine].
    Hara M; Ohfuji S; Fukushima W; Hirota Y
    Nihon Eiseigaku Zasshi; 2013; 68(3):153-60. PubMed ID: 24077487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving seasonal and pandemic influenza vaccines.
    Saville M; Marsh G; Hoffenbach A
    Influenza Other Respir Viruses; 2008 Nov; 2(6):229-35. PubMed ID: 19453399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influenza vaccine: globalization of public health stakes].
    Collin N; Briand S
    Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands.
    Nuño M; Chowell G; Gumel AB
    J R Soc Interface; 2007 Jun; 4(14):505-21. PubMed ID: 17251132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.
    Kreijtz JH; Osterhaus AD; Rimmelzwaan GF
    Hum Vaccin; 2009 Mar; 5(3):126-35. PubMed ID: 18948744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEW technologies for meeting the global demand for pandemic influenza vaccines.
    Fedson DS
    Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccines: the good, the bad, and the eggs.
    Schultz-Cherry S; Jones JC
    Adv Virus Res; 2010; 77():63-84. PubMed ID: 20951870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza pandemic preparedness action plan for the United States: 2002 update.
    Strikas RA; Wallace GS; Myers MG
    Clin Infect Dis; 2002 Sep; 35(5):590-6. PubMed ID: 12173135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Containing pandemic influenza with antiviral agents.
    Longini IM; Halloran ME; Nizam A; Yang Y
    Am J Epidemiol; 2004 Apr; 159(7):623-33. PubMed ID: 15033640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.